PROSTVAC(TM) data pr
PROSTVAC(TM) data præsenteret på ASCO Annual Meeting påviser vaccinens potentiale til at forlænge livet signifikant for patienter med fremskreden prostatacancer
May 30, 2009 17:23 ET | Bavarian Nordic A/S
Detaljerede data fra et randomiseret fase 2 studie med PROSTVAC(TM) blev i dag præsenteret på ASCO Annual Meeting i Orlando i USA. Præsentationen blev afholdt af Professor Philip Kantoff, MD,...
Belinostat has activ
Belinostat has activity in thymoma. Data presented at ASCO
May 30, 2009 14:00 ET | Topotarget
Announcement No. 24-09 / Copenhagen, 30 May 2009 TopoTarget A/S Symbion Fruebjergvej 3 DK 2100 Copenhagen Denmark Tel: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr:...
Infinity Pharmaceuticals, Inc. Logo
Infinity Reports Encouraging Clinical Data for IPI-504 at ASCO 2009
May 30, 2009 14:00 ET | Infinity Pharmaceuticals, Inc.
Phase 2 Data Show Partial Responses and Generally Well-Tolerated Safety Profile in Patients with Advanced Non-Small Cell Lung Cancer Phase 1 Study Demonstrates Combinability of IPI-504...
NASDAQ OMX: GNW Test
NASDAQ OMX: GNW Testmessage 20090530 16:07 - TO BE DELETED
May 30, 2009 10:07 ET | OMX Nordic Exchange
NASDAQ OMX: GNW Testmessage 20090530 16:07 - TO BE DELETED ...
Threshold Pharmaceuticals Presents Encouraging Data From Clinical Trials of TH-302 for Solid Tumors
May 30, 2009 08:00 ET | Threshold Pharmaceuticals, Inc.
REDWOOD CITY, Calif., May 30, 2009 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced clinical trial results related to its clinical stage hypoxia-activated prodrug,...
Positive data on ora
Positive data on oral belinostat in phase I dose escalating study in Lymphoma presented at ASCO
May 30, 2009 08:00 ET | Topotarget
Announcement No. 23-09 / Copenhagen, 30 May 2009 TopoTarget A/S Symbion Fruebjergvej 3 DK 2100 Copenhagen Denmark Tel: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr:...
Immunomedics.png
Immunomedics Reports Updated Results of Milatuzumab in Dose-Escalation Study for Multiple Myeloma
May 30, 2009 08:00 ET | Immunomedics, Inc.
-- First Clinical Study of Anti-CD74 Antibody -- -- Results Presented At 2009 Annual Meeting of ASCO -- ORLANDO, Fla., May 30, 2009 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a...
Workscape Opens "Liv
Workscape Opens "Live" Corporate Compensation Governance Survey for WorldatWork Attendees
May 30, 2009 07:29 ET | Workscape
MARLBOROUGH, MA--(Marketwire - May 30, 2009) - Workscape, Inc., a leading provider of outsourced benefits and talent management, will launch a live survey on the business-critical topic of corporate...
Gainey & McKenna First to File Class Action On Behalf of Idearc Investors -- IDARQ
May 29, 2009 21:00 ET | Gainey McKenna & Egleston
NEW YORK, May 29, 2009 (GLOBE NEWSWIRE) -- Gainey & McKenna was the first to file a class action lawsuit in the United States District Court for the Southern District Texas, Dallas Division, on...
Given Imaging Announces Conference Call to Review PillCam(R) SB Video Capsule and Bravo(R) pH Monitoring System Abstract Highlights at Digestive Disease Week
May 29, 2009 19:39 ET | Given Imaging
YOQNEAM, ISRAEL--(Marketwire - May 29, 2009) - Given Imaging (NASDAQ: GIVN) today announced that the company will host a conference call on June 3, 2009 to review PillCam SB video capsule and Bravo...